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Abstract
The structure and functional relationship between the melanocortin-2 receptor
(MC2R) and adrenocorticotropic hormone (ACTH) is the most complex of the
melanocortin gene family. Prior studies had been done on amniote tetrapod MC2Rs (e.g.,
mammals); this study analyzed the expression and activation of MC2R by an anamniote
tetrapod, Xenopus tropicalis (xtMC2R). An immunofluorescence approach, done on the
expression of xtMC2R in Chinese Hamster Ovary cells (CHO cells), indicated that the
trafficking of xtMC2R to the plasma membrane required co-expression with a tetrapod
MRAP1(melanocortin-1 receptor accessory protein). A cAMP-reporter assay was used
to show that xtMC2R can activated by human ACTH(1-24, but not by α-MSH. These
two properties are also observed for human MC2R, and are common for tetrapod MC2Rs
in general. Alanine-substitution analogs of hACTH(1-24) were used to deduce a possible
mechanism for the activation of xtMC2R. These studies showed that alanine substitutions
to the HFRW motif in hACTH(1-24) eliminated activation of the receptor. Furthermore,
the alanine-substitution analysis revealed that positions 15 and 16 in the KKRRP motif
are more important for the activation of xtMC2R than positions, 17 through 19. Finally,
the alanine-substitution assays coupled with analysis of internally truncated analogs of
the GKPVG motif resulted in decreased or complete elimination of xtMC2R activation.
These data were used to construct a proposed three step model for the activation of
ii

MC2R. The final goal of this thesis was to identify the region of the receptor involved in
the docking of the KKRRP motif of ACTH. Based on a model of MC2R, these
experiments used alanine substitution site-directed mutagenesis to analyze the
transmembrane 4 (TM4), extracellular loop 2 (EL2), and transmembrane 5 (TM5) region
of xtMC2R. These experiments revealed that the following mutations had the greatest
effect on the sensitivity (EC50 value) of xtMC2R: I/A175, F/A178, and I/A184. These
results were compared to site-directed mutagenesis studies done on human and rainbow
trout MC2Rs. Collectively, these analyses revealed that all three MC2Rs have docking
sites for the KKRRP motif of ACTH that are similar in general location, and mostly
similar in 3-dimensional structure, but that are not identical. The evolutionary
implications of these observations are discussed.
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Introduction
Melanocortin Receptor Family: G-Coupled Protein Receptors
The melanocortin receptors (MCRs) are a family of hormone-activated receptors
that influence a number of physiological functions in mammals. The melanocortin
receptor family consists of five different receptors, which were named in the numerical
order in which they were cloned from the human genome (Cone, 2006). More so, each of
these receptors is regulated by its own gene, and these receptors are expressed in different
cells and tissues (Cone, 2006) throughout an organism. Melanocortin receptors are G
protein-coupled receptors (GCPRs) that belong to the rhodopsin/β2-adrenergic-like family
of GPCRs. G protein-coupled receptors are the largest group of cell surface receptors,
and all these receptors use guanine nucleotide-binding proteins (G proteins) as
transducers. All GCPRs have seven transmembrane domains that are linked by
extracellular and intracellular protein loops. More specifically, the extracellular domains
allow for the binding of specific ligands, which causes a conformational change in the
receptor. In turn, this conformational change causes the intracellular G protein to be
activated. Finally, a subunit of the G protein interacts with either an ion channel or an
enzyme to illicit a biological response in the target cell. In the case of the melanocortin
receptors the enzyme that is activated is adenylyl cyclase, and this enzyme generates the
second messenger cyclic AMP (cAMP). The increase in the intracellular concentration of
1

cAMP results in the activation of protein kinase A, and this enzyme in turn, can activate
transcription factors, interact with channels, or affect the activity of enzymes. The end
result is a biological response within a cell (Cooper & Hausman, 2009).
The MCRs appear to be the smallest GCPRs in terms of amino acid length, and
have relatively short N- and C- terminal ends (Cooray & Clark, 2011). In terms of the
location and function of the melanocortin receptors (Figure 1; Cone, 2006), MC1R is
located on melanocytes, in areas of the brain, and on macrophages. This MCR plays a
role in pigmentation (melanocytes), body temperature regulation (CNS), and has antiinflammatory properties. MC3R is predominantly expressed in the brain, but can be
found in the placenta, stomach and pancreas; its main function lies in energy metabolism.
MC4R is expressed mainly in the brain, as well as the autonomic nervous system, and
spinal cord where it plays a role in the regulation of food consumption and energy output.
MC5R is expressed in many different tissues including skin, adrenal and exocrine glands.
It is thought to play a role in the production of types of lipids, as well as some regulation
of the immune system. Finally, MC2R is located in the adrenal cortex, and is involved in
the initiation of steroidogenesis; the production of the glucocorticoid, cortisol. However,
this receptor is also expressed the in the skin (melanocytes), as well as, in adipocytes.
MC2R is unlike any of the other melanocortin receptors because of its unique
intracellular trafficking properties and ligand selectivity.
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Figure 1: Melanocortin Receptor Expression, Function, and Ligand Selectivity

(Figure adapted from Cone, 2006)
Melanocortin Peptides Derived from Proopiomelanocortin
The melanocortin receptors are activated by hormones derived from the
proopiomelanocortin (POMC) gene, which is a member of the opioid/orphanin gene
family (Dores & Baron, 2010). This gene is expressed in the pituitary gland, and is
responsible for the production of POMC proproteins in two different types of pituitary
cells: corticotropic and melanotropic cells. Located at the anterior pituitary, the
corticotropic cells are responsible for the production of the hormone, adrenocorticotropin
(ACTH), by the specific and selective posttranslational cleavage involving proprotein
convertase 1/3 (PC 1/3) (Cone, 2006). At the intermediate pituitary, the melanotropic
cells produce various hormones including: γ-MSH, α-MSH, CLIP, β-MSH, and βendorphin by posttranslational events involving PC1/3, as well as, PC2 (Dores & Baron,
2010). An illustration of these specific endoproteolytic cleavage events can be seen in
Figure 2.

3

Figure 2: Illustration of POMC Post-Translational Cleavage Products

(Figure adapted from Cone, 2006)
A striking feature with respect to the evolution of the POMC gene is the
remarkable degree of conservation in the organization of the precursor and the number of
melanocortin-related sequences in organisms ranging from the jawless fishes to mammals
as illustrated in Figure 3 (Vallarino et al., 2012).
Note also that α-MSH is the first 13 amino acids of ACTH (Figure 4). These
peptides have the HFRW motif which is an essential feature of melanocortin-related
peptides (Schwyzer, 1977). β-MSH and γ-MSH are located at completely different
cleavage sites within POMC. These polypeptides share the HFRW motif with ACTH and
alpha-MSH as well.

4

Figure 3: POMC Gene Phylogenic Tree

(Vallarino et. al, 2012)
Figure 4: Human & Xenopus tropicalis POMC Sequence and Peptides
A) Vertebrate POMC Sequences
Human POMC:
MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNG
DEQPLTENPRKYVMGHFRWDRFGRRNSSSSGSSGAGQKREDVSAGEDCGPLPEGGPEPRSDGAKP
GPREGKRSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEPKRELTGQRLREGDGPDGPA
DDGAGAQADLEHSLLVAAEKKDEGPYRMEHFRWGSPPKDKRYGGFMTSEKSQTPLVTLFKNAIIK
NAYKKGE
Xenopus tropicalis POMC:
MFRPLWGCSLAILGAFIFHVGEVQGQCWESSRCADLSSEDGVLECIKACKMDLSAESPVFPGNGH
LQPLSESIRKYVMTHFRWNKFGRRNSTGNDGSSSGYKREDISNYPVFNLFPVSDNMEQNAQGDNM
EGEPLDRQENKRAYSMEHFRWGKPVGRKRRPIKVYPNGVEEESSENYPMELRRELSLELDYPDID
LDEDIEDNEVESALTKKNGNYRMHHFRWGSPPKDKRYGGFMTPERSQTPLMTLFKNAIIKNTHKK
GQ
Alpha-MSH
ACTH
Beta-MSH
Gamma-MSH
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B) Alignment of Conserved HFRW Domain for X. Tropicalis POMC Melanocortin Peptides

alpha-MSH
ACTH(1-39)
beta-MSH
gamma-MSH

10
20
30
40
....|....|....|....|....|....|....|....|.
--AYSMEHFRWGKPV---------------------------AYSMEHFRWGKPVGRKRRPIKVYPNGVEEESSENYPMEL
NGNYRMHHFRWGSPPKD-------------------------KYVMTHFRWNKF---------------------------

As shown in Figure 1, the MCRs can be activated by different peptide hormones
derived from POMC. Based on studies on mammals, the MC1R, MC4R, and MC5R, all
have a higher affinity for α-MSH, than ACTH, β-MSH, or γ-MSH, while MC3R interacts
with γ-MSH, α-MSH, β-MSH, and ACTH with equal favorability. Although these
different receptors seem to prefer one hormone or ligand over the other melanocortin
peptides, they all respond to ACTH in varying degrees of efficacy (Dores & Lecaude,
2005). However, MC2R can only be activated by ACTH, and therefore, a closer look at
this polypeptide is warranted.
A Highly Conserved Melanocortin Peptide: Adrenocorticotropin Hormone (ACTH)
Human ACTH is composed of 39 amino acids and can be found in all vertebrates
because of the important role this hormone plays in glucocorticol biosynthesis. However,
it should be noted that within the ACTH peptide, only a certain number of amino acid
residues are needed for functionality; the critical domains lie within the first 24 amino
acid residues (Dores & Lecaude, 2005). In Figure 4, the POMC amino acid products are
designated by different colors. Both human and Xenopus tropicalis (amphibian) ACTH
sequences are strikingly similar with only a few differences lying within the 39 amino
acid residues, which suggests that the conservation in the melanocortin peptide sequence
is of importance for the fitness of the organism. As noted, all four melanocortin peptides
shown in Figure 4.b, have the four amino acid motif, histidine-phenylalanine-arginine6

tryptophan (HFRW). The HFRW domain within a melanocortin peptide is required for
the activation of all of the melanocortin receptors. This relationship was established by
studies done in the 70’s on the MSH receptor (i.e., MC1R) and the ACTH receptor (i.e.,
MC2R) as summarized in the review article by Robert Schwyzer (Schwyzer, 1977).
In Schwyzer’s review (1977), he suggests that the location of the “activation
motif” within ACTH was within the first 24 amino acids of the polypeptide because of in
vivo experiments carried out with elongated or shortened sequences of human ACTH(139). He demonstrated that high corticotropic activity was observed with human ACTH Nterminal amino acid residues 1-19, 1-20, 1-23, and 1-24. Thus, he found that H6 F7 R8 W9
motif located within amino acid residues 1-10 of ACTH was essential for activation of
the ACTH receptor. Furthermore, he proposed that another site within ACTH(1-24) acted
as a type of “address” domain to direct or to position the HFRW stimulatory domain in
the proper position on the receptor so that activation of the ACTH receptor would occur.
He proposed that this important address sequence is located at residues 15-18 at the
Lysine-Lysine-Arginine-Arginine or KKRR motif (Schwyzer, 1977). At this stage it
would desirable to focus on the nature of the ACTH (aka MC2R) receptor.
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The Physiological Relationship between Glucocorticoid Production, ACTH, & MC2R
In terms of the MC2R receptor and glucocorticoid production, the hypothalamuspituitary-adrenal axis (HPA) should be mentioned to understand how this receptor is part
of a neuroendocrine circuit that can respond to stress. As shown in Figure 5,
Corticotropin-releasing factor (CRF) is a 41-amino acid polypeptide that is found in the
hypothalamus, and was first isolated from a sheep; CRF plays an important role in
regulating the stress response. When stress is introduced to an organism, CRF mRNA
levels elevate in parts of the brain, such as the paraventricular nucleus (PVN), locus
coeruleus, Barrington’s nucleus and bed nucleus of stria terminalis. As CRF levels
increase within the hypothalamus, CRF receptor type 1 (CRF1 receptor) is expressed on
the anterior pituitary. CRF is released from the hypothalamus into a capillary bed, the
median eminence, where it binds to the CRF1 receptor (Kageyama & Suda, 2009). CRF1
receptor stimulation activates the synthesis and secretion of ACTH from the corticotropic
cells located within the anterior pituitary. In turn, ACTH secretion activates
glucocorticoid production by binding to the MC2R receptor located on the adrenal cortex
(Kageyama & Suda, 2009). As illustrated in Figure 5, the HPA axis is regulated by
negative feedbacks loops, which turn off the production of ACTH or CRF in response to
elevated levels of circulating cortisol.
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Figure 5: Hypothalamus-Pituitary Axis Involving Cortisol Release

http://www.montana.edu/wwwai/imsd/alcohol/Vanessa/vwhpa.htm
When ACTH is present, the MC2R is specifically expressed to activate a
biosynthetic pathway to release cortisol from the target cell of the adrenal cortex. As seen
in Figure 6, the biosynthesis of this hormone occurs within the zona fasiculata and zona
reticularis of the adrenal cortex. The steroid, cholesterol, is broken down by enzymes
into an intermediate, progesterone, and then more specific enzymatic reactions produce
cortisol (Barrett, 2003). Cortisol’s functions span throughout they physiological system,
and therefore, it is considered an important glucocorticoid hormone. Mainly, it functions
to regulate stress and restore homeostasis within the body. Although its primary targets
involve metabolism, it can be involved in ion transport and the physiology of the immune
system as well. Additionally, when acute stress is introduced to the body, cortisol
stimulates gluconeogenesis, the synthesis of glucose, in the liver (Cooper & Hausman,
9

2009). Prior to 1992, while there was no doubt that an “ACTH’ receptor was present on
adrenal cortex cells, the biochemical structure of that receptor had not been determined.
This discovery will be discussed next.
Figure 6: Biosynthetic Pathway of Adrenal Steroid Hormones

http://openi.nlm.nih.gov/detailedresult.php?img=2908652_wjem-11-161f1&req=4
MC2R: A Unique Melanocortin Receptor
In 1992, Mountjoy et. al, knew that ACTH and β-endorphin were co-expressed in
the anterior pituitary in response to stimulation by CRF. Also, they acknowledged the
relationship between ACTH and α-MSH in that both these neuropeptides bind to G
protein-coupled receptors found in the brain, as well as, melanocytes, and the adrenal
cortex. However, the sequence and site of expression of these specific G protein-coupled
receptors was yet to be discovered. Therefore, Mountjoy’s group hypothesized that these
specific receptors would share sequence similarity with other G protein-coupled
10

receptors. First, they determined by DNA sequencing, two PCR fragments that encoded
G protein-coupled receptors one of which was a substantial part of the MSH-R, or the
MC1R receptor. By carrying out a Northern hybridization assay, this group discovered
that more than one fragment held specific sites of expression in melanocytes and the
adrenal cortex. Furthermore, they screened two sequences against the human genomic
library, and isolated the gene sequences of the MC1R and MC2R receptor, which they
referred to as the MSH-R and ACTH-R respectively. To further support their findings of
these genomic sequences, they wanted to functionally test these genes with their
corresponding peptide, and therefore, carried out functional assay experiments. In these
experiments, specific cell lines were used to express the MSH-R and ACTH-R. The
MSH-R and ACTH-R were then stimulated with different concentrations of their
corresponding neuropeptides, and increased cAMP levels were detected in the cells.
Therefore, these assays represent compelling evidence that they had discovered both
MSH-R and ACTH-R genes. However, the location of these two receptors was still
lacking in experimental data. First, they carried out a Northern Blot to test how much
mRNA could be detected in different types of tissues. They found that an abundance of
MSH-R mRNA could be found in human melanocyte samples. Also, this group found the
presence of ACTH-R mRNA in monkey adrenal gland tissue. Overall, Mountjoy’s group
provided strong evidence two separate genes code for MC1R and MC2R, as well as,
proving that these genes are expressed in specific tissues within an organism (Mountjoy
et al., 1992).
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Although Mountjoy’s group was able to express and functionally test the human
MC2R, they were limited to using a mammalian cell line, Cloudman S91 melanoma cells.
This cell line endogenously expressed MC1R, thus making analysis of the unique
properties of MC2R difficult to interpret in this particular cell line. However, Rached et
al. (2005) successfully expressed the human MC2R in two different eukaryotic cell lines,
M3 melanoma and HEK293, in 2004. In this study Rached et al. (2005) first stably
expressed the human MC3R and MC4R genes in HEK293 cells. In these experiments
each melanocortin receptor was tagged at the C-terminus with an enhanced green
fluorescent protein (EGFP). Thus the receptors could be visualized using fluorescent
microscopy. The EGFP-tagged human MC3R and MC4R fluoresced along the plasma
membrane of the HEK 239 cells, and this was to be expected because of previous
research in 2000 and 2003 (Rached et al. (2005). However, when EGFP- tagged human
MC2R was expressed in HEK293 cells, the labeled receptor could be detected within the
cytosol of these cells, not on the plasma membrane. These results suggested that the
human MC2R required some chaperone to facilitate trafficking of the receptor to the
plasma membrane (Rached et al., 2005).
Clinical observations also indicated that some chaperone may be needed to
facilitate the activation of MC2R. Familial glucocorticoid deficiency (FGD) is a genetic,
autosomal recessive disease where individuals become insensitive to ACTH levels. In
turn, this ACTH resistance causes alarmingly low glucocorticoid output from the adrenal
cortex, accompanied by high levels of ACTH. The deficient levels of cortisol in the
circulatory system interrupt the development of some organ systems in newborns and this
12

condition can be fatal. Mutations within the MC2R receptor are responsible for at least
one fourth of FGD cases and this condition is designated as Type I FGD (Hinkle &
Sebag, 2009). Several different mutations within the human MC2R have been shown to
cause Type 1 FGD, and in turn, individuals become insensitive to ACTH (Chan et al.,
2008). Another 50% of FGD cases are caused by errors in the glucocorticoid biosynthetic
pathway. However, in approximately 25% of FGD cases there is no evidence of mutation
in MC2R, and there are no errors in the expression of the enzymes that make cortisol.
Clearly in these patients a protein that interacts with MC2R is the problem.
MRAP: An Essential Accessory Protein for MC2R Trafficking & Functionality
Melanocortin Receptor Accessory Protein (MRAP) was discovered by clinical
researchers, Metherell et al, (2005) who studied a group of individuals diagnosed with
FGD, but who had no mutations within their MC2R receptor. Therefore, they mapped a
region of the human genome that was connected to FGD, and studied the expression of
30 susceptible genes in the adrenal cortex, while comparing genes from the liver and
brain (Metherell et al., 2005). By comparing and contrasting these specific genes, the
group was able to identify a gene that encoded for protein with a single transmembrane
spanning domain. Tissue analysis observed that the protein’s gene, C21orf61, was
expressed in adrenal tissue, but not in the brain or liver (Webb & Clark, 2010). As it
turned out, this small protein played a major role in the successful expression of a
functional MC2R receptor in adrenal tissue. Interestingly, MRAP is the first GPCR
accessory protein to be implicated in causing a disease, and 9 different mutations within
MRAP have been found in FGD patients. Because the mutations causing FGD were
13

found in MRAP and not the MC2R receptor, this form of the disease was designated as
Type II FGD. Additionally, MRAP was previously identified as fat cell-specific low
molecular weight protein (Falp) because of the appearance of its transcript only when
differentiation occurred within adipocytes (Hinkle & Sebag, 2009).
As mentioned above, MRAP is a small protein consisting of one transmembrane
domain. MRAP mRNA can be found in many parts of the mammalian body, such as the
adrenal cortex, lymph nodes, brain, testis, breast, thyroid, and adipose tissue. The gene
that encodes for this mammalian accessory protein consists of 6 exons. Alternate splicing
of these exons can create two different MRAP products: Human MRAPα and MRAPβ
(Hinkle & Sebag, 2009). The exons 3 and 5 encode for MRAPα, which is made up of 172
amino acids. On the other hand, exons 4 and 6 give rise to the 102 amino acid isoform,
MRAPβ. However, the crucial transmembrane domain of MRAP is encoded by exon 4,
and therefore, the two isoforms of MRAP have identical N-termini, as well as,
transmembrane domains (Webb and Clark, 2010). Specifically, the 37 amino acid Nterminal sequence, the 23 amino acid transmembrane domain, and the first 9 residues of
the C-terminal are identical in MRAPα and β (Hinkle & Sebag, 2009). However, MRAPα
and β differ by many residues in their C-termini (Webb and Clark, 2010). Therefore,
these findings suggest a level of conservation in the amino acid sequence of MRAP;
particularly at the N-terminal and transmembrane domain. Although these isoforms of
MRAP differ slightly in their C-termini, it is interesting to find that Roy et al. (2007)
discovered cAMP production occurring within a heterologous cell line while
coexpressing the MC2 receptor and the MRAP isoforms.
14

In terms of MRAP’s structural properties, it is necessary to mention the
importance of MRAP’s orientation in the endoplasmic reticulum (ER) and the plasma
membrane because of its complex interaction with the MC2R. Through topology analysis
programming, Viklund & Elofsson (2004) predicted that MRAP was a type II integral
membrane protein with a C-terminal that faced the inside of the ER and Golgi apparatus.
On the other hand, it was hypothesized that this same C-terminus of MRAP was exposed
to the exterior of the cell when MRAP was expressed on the cell membrane.
Interestingly, Sebag and Hinkle (2008) found that both mouse MRAP’s N- and C- termini
were oriented extracellularly while being expressed on the surface of CHO cells.
Therefore, a dual topology of MRAP was discovered, and found to be completely
independent of the MC2R receptor (Hinkle & Sebag, 2009). Therefore, to confirm
MRAP’s dual topology, Hinkle and Sebag performed two critical experiments where
endogenous MRAP was expressed in adrenocortical cells. By tagging MRAP’s N- and Ctermini, they found that both ends of MRAP were found on the endoplasmic reticulum as
well as the plasma membrane. In another experiment, they used an adrenal cell line, OS3,
where the MC2 receptor is not endogenously expressed, and found that the tagged MRAP
produced the same results on the surface of the cell. Therefore, this suggests that
MRAP’s dual topology occurs independently of the MC2R. Furthermore, studies have
generated convincing data that MRAP’s dual topology implies formation of a
homodimer. Corray et al. (2008) found that MRAP’s size was comparable to that of
dimers by using electrophoresis and mass spectrometry to confirm molecular weight.
Furthermore, antibodies were used to test against two differently tagged MRAPs which
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were coexpressed in CHO cells. Immunoprecipitation found that both MRAPs
coprecipitated, indicating the presence of dimer formation (Corray et al., 2008). In
addition, Hinkle and Sebag (2008) performed a set of experiments where they tagged
both N- and C-termini, and found that the C-terminus of MRAP existed in both
glycosylated and unglycoslyated forms suggesting that MRAP structure forms an
antiparallel homodimer. Therefore, this evidence of MRAP’s dimeric properties suggests
that this accessory protein would form a complex with the MC2 receptor, and in turn,
facilitate proper function of the receptor.
The direct interaction of MRAP with the MC2 receptor is required for proper
trafficking, and activation of MC2R. Webb et al. (2009) suggests that the functional
domain of MRAP lies within the N-terminus and the transmembrane domain because of
high level of conservation within these two regions of the accessory protein. By using
truncation constructs of MRAP at both regions they were able to provide strong evidence
that the transmembrane domain was responsible for the direct interaction between human
MRAP and the MC2 receptor. Furthermore, they discovered that the N-terminus of
MRAP is required for the MC2 receptor’s surface expression, as well as, the receptor’s
affinity to be activated by ACTH (Webb et al., 2009). In addition, multiple research
studies showed that cAMP production is affected by the presence or absence of MRAP. If
MRAP was not expressed with the MC2 receptor, then cAMP production was
insignificant. On the other hand, cAMP production increased significantly when MRAP
and the MC2 receptor were co-expressed in mammalian cells lines (Metherell et al.,
2005; Roy et al., 2007; Hinkle & Sebag, 2008). Figure 7 illustrates how MRAP
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interaction and MC2R activation can be broken down in three steps. First, the MC2
receptor and MRAP form a complex at the endoplasmic reticulum. Second, MRAP
facilitates the trafficking of the MC2R to the plasma membrane. Third, MRAP not only
enables the receptor to traffic to the membrane, but also increases the binding affinity of
the receptor for ACTH. Finally, a signal is transducted into the intracellular compartment
of the cell to produce cAMP.
Figure 7: Interaction of MC2 Receptor and MRAP

http://www.sciencedirect.com/science/article/pii/S1521690X08001048
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Evolution of the Melanocortin-2 Receptor
Comparative studies have proposed that the evolution of the melanocortin
receptor family is complex. What seems to be even more perplexing is the evolution of
one melanocortin receptor in particular: the MC2R. This receptor’s evolution creates an
interesting story because of its intimate relationship with POMC products, ACTH, and
MRAP. While MC2R depends on these two components for proper functionality and
trafficking, their evolutionary trends seem to parallel that of the MC2 receptor. Therefore,
a comparative analysis on the origin of the melanocortin receptors is necessary to
understand the occurrence of the MC2R, as well as, observe any similar trends in POMC
and MRAP evolution. It should be mentioned that genomic databases have revealed the
absence of orthologous genes in protostomes, as well as, many deuterostomes. On the
other hand, genomic comparisons have revealed MCR-related genes in hagfish, lamprey,
cartilaginous fish, teleost, and tetrapod genomes. Therefore, these genomic data suggests
that the MCR family is only found in chordates (Dores, 2013).
In 1994, comparative studies suggested that the melanocortin receptor family
evolved from an ancestral gene found in protochordates (Holland et al., 1994). This
single gene was subjected to two separate genomic duplication events, in which the first
created two paralogous genes, and the second yielded four paralogous genes (Holland et
al, 1994). The first duplication event seems likely because of two MCR genes that have
been cloned from the lamprey genome (Haitina et al., 2007; Baron et al., 2008). Also,
evidence of the second genomic duplication comes from bony fish in which MC1R,
MC2R, MC4R and MC5R genes have been observed in the fugu genome while an
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ortholog of the MC3R gene is found in zebrafish (Klovins et al., 2004; Baron et al., 2008;
Ringholm et al., 2002). Furthermore, it was proposed that the MC2R and the MC5R
receptors resulted from a local gene duplication dating back to the early gnathostomes
because these receptors’ genes are found on the same chromosome (Fredriksoon et al,
2003; Klovins et al., 2004; Baron et al, 2008). Therefore, a phylogenic tree of the
melanocortin receptors was established due to sequence alignments of the receptors from
different chordates. Figure 8 illustrates an early rendition of melanocortin receptor
evolution as a result of the genome duplication events that lead to five distinct
melanocortin receptors (Baron et al, 2008). Although this seems to be a logical
hypothesis, the evolution of the melanocortin receptor family proved to be more complex
because of recent findings involving the MC2R, MC4R, and MC5R.
Although the MC2R and MC5R genes are located in close proximity to one
another on the same chromosome, their evolutionary origins have been called in question.
Alignment of the MC2R and MC5R amino acid sequences reveals that these two
receptors differ greatly from one another. Therefore, this would suggest that a local gene
duplication of the MC2R and MC5R genes proves to be a weak hypothesis without
further investigation. Therefore, another evolutionary scenario is introduced to include
the MC4R because of its similarity in amino acid sequence with that of the MC5R.
Therefore, these data implies that the MC5R gene resulted from a local duplication of the
MC4R gene (Vastermark and Schioth, 2011).
In turn, a new evolutionary phylogeny hypothesis of the melanocortin receptors
could be established to include the MC2R/MC5R local duplication and the MC4R/MC5R
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relationship. Figure 9 illustrates this new explanation of melanocortin evolution where
the MC4R gene is considered the ancestral gene (Dores, 2013). If the MC4R gene is the
“original” melanocortin gene, then genome and local gene duplications would result in
the paralog genes containing a conserved motif of amino acids from the ancestral MC4R
gene. Synteny studies have shown that it is possible for the MC2R/MC5R gene to
undergo a local duplication dating back to ancestral gnathostomes (Schioth et al., 2003;
Dores, 2013). Therefore, it has been suggested that this duplication event selected for the
MC5R gene, and therefore, retained sequence similarities with its ancestral gene.
Consequently, its “partner” gene, the MC2R, underwent a different fate. The MC2R gene
was subjected to mutations, and in turn, its functionality would be forever different from
the rest of the melanocortin family (Dores, 2013).
Main Objectives
These observations have focused on the structure, functionality, and evolution of
the mammalian MC2 receptor. Also, the mammalian MC2R’s activation by ACTH has
been carefully analyzed in past studies. More specifically, past research has asked these
questions: Does the mammalian MC2 receptor have specific binding sites for ACTH? Do
these binding sites rely on crucial ACTH amino acid motifs to ensure proper function of
the MC2 receptor? (Liang, 2013) has tried to answer these questions about the human
MC2R. The data have suggested that key ACTH motifs exist within the first 24 amino
acids, and therefore, corresponding binding sites on the mammalian MC2 receptor can be
established within the receptor’s sequence. Therefore, could these same questions be
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asked of a different species of chordate to gain a better understanding of the MC2
receptor’s evolution?
Based on these findings of the mammalian MC2R, this study has two different
objectives, which involve the amphibian, Xenopus tropicalis, MC2 receptor. The first
objective was to answer this question: what regions of ACTH are responsible for the
activation of X. tropicalis MC2 receptor? Our hypothesis suggests that there are three
important regions of ACTH that are required for the successful activation of the MC2
receptor. As mentioned above, ACTH is a polypeptide chain consisting of 39 amino
acids. However, only the first 24 amino acids are required for activation of the receptor
because of the high level of conservation within this area of the peptide (Schwyzer,
1977). Although the wild type X. tropicalis MC2R is utilized in the following
experiments, we used the mammalian melanocortin, human ACTH(1-24). We were able
to use the mammalian ACTH(1-24) because of its high level of sequence similarity with
the amphibian ACTH peptide (Figure 3A). The first zone of ACTH(1-24), Zone A,
consists of amino acids 6-9, which are HFRW (Histidine-Phenylalanine-ArginineTryptophan). This crucial motif is found in several of the melanocortin peptides (Cone,
2006). The second region we analyzed was Zone B, which was made up amino acids 1014, GKPVG (Glycine-Lysine-Proline-Valine-Glycine). The third region of ACTH(1-24),
Zone C, is made up of amino acids KKRRP (Lysine-Lysine-Arginine-Arginine-Proline).
To test the importance of these three regions in ACTH(1-24), we replaced individual
amino acids within each zone, and stimulated the wild type X. tropicalis MC2 receptor
with these ACTH(1-24) analogs to produce a dose response curve. By analyzing these
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zones of ACTH(1-24), we believe that the activation of the X. tropicalis MC2R could be
quite similar to that of human MC2R. Therefore, the hypothesized mechanism for the X.
tropicalis MC2R can be broken down into three major steps. First, the C-terminus region
of ACTH(1-24), Zone C, would make contact with its corresponding binding site on the
X. tropicalis MC2R. In turn, this specific binding induces a conformational change in the
receptor, and the second binding site is exposed. Third, Zone A, HFRW, is able to bind to
the receptor’s second site, and activate the G-protein of the receptor (Baron et al. 2008;
Liang, 2013).
The second objective of this study focused on this question: what regions of the
amphibian MC2 receptor bind to ACTH? Since we believe that the amphibian MC2R
activation is similar to that of the mammalian MC2R, it would be logical to suggest that
these receptors would have a similar binding complex model. The theoretical model
illustrates the amphibian receptor having two binding pockets like that of the human
receptor. The first binding pocket is utilized as a docking pocket for the C-terminal amino
acids of ACTH(1-24), Zone C. The second binding pocket is responsible for the binding
of the HFRW motif, Zone A, so that activation of the receptor may occur. It has been
hypothesized that the second binding pocket consists of the receptors transmembrane
regions 4 (TM4) and 5 (TM5), as well as, extracellular loop 2 (EC2). To test this second
binding pocket hypothesis, we replaced single amino acids within TM4, TM5, and EC2
regions with alanine, and then stimulated these mutants with ACTH(1-24) to produce a
dose response. Additionally, it is important to note that Zone B is utilized as an adapter
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region of ACTH(1-24), and without this sequence of residues Zone C and Zone A would
not be properly situated within the binding pockets of the receptor (Liang, 2013).
Figure 8: “Early” Melanocortin Receptor Phylogenic Tree

Figure 9: Revised Melanocortin Receptor Phylogenic Tree

(Both Figures are adapted from Dores, 2013)
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Materials and Methods
Tissue Culture
Experiments were done utilizing Chinese Hamster Ovary (CHO) cells (ATCC,
VA). The cells were grown in Kaighn’s Modification of Ham’s F12K media supplied by
ATCC. Media was supplemented with 10% fetal bovine serum, 10 unit/ml penicillin, 100
µg/ml streptomycin, and 100 µg/ml normacin (CHO media) The cells were grown in a 25
cm3 tissue culture flask with vent cap by CELLTREATTM, and maintained in an
incubator with 95% air, 5% CO2 at 37ºC, and exposed to humidity. When the CHO cells
reached 70% confluence, cells were split into new culture flasks using 0.05% trypsin/0.53
mM EDTA produced by CORNING cellgroTM.
DNA Constructs
The amphibian, Xenopus tropicalis, MC2R (xtMC2R; Accession No.:
XP_003215733) cDNA construct was synthesized by GenScript (Piscataway, NJ). This
receptor was tagged at the N-terminus with a V-5 epitope, and inserted into a
pcDNA33.1+ vector. In addition, the mammalian, Mus musculus (mouse), MRAP1
(mMRAP1; Accession No.: NM_029844) was synthesized by GenScript, tagged at its Nterminus with a FLAG epitope, and inserted into a pcDNA3.1+ vector as well. The
cAMP reporter, CRE-Luc (Chepurny and Holz, 2007), was provided by Dr. Patricia
Hinkle (University of Rochester, NY). A set of alanine-substituted mutants of the wild
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type Xenopus tropicalis MC2R was also made by GenScript. Each of these cDNA
constructs had a V5 epitope tag and was inserted into the pcDNA3.1+ vector.
Individually, mutations were introduced to the Xenopus tropicalis MC2R by site-directed
mutagenesis. Single alanine substitutions were made at TM4, EC2, and TM5 are
illustrated in Figure 10.
ACTH Analog Peptides
The melanocortin peptide used in the experiments was human ACTH(1-24), and
this synthetic hormone was purchased from Sigma-Aldrich Inc. located in Saint Louis,
MO. Additionally, the human ACTH(1-24) analogs include alanine substitutions, as well
as, truncated forms of ACTH(1-24) which were made by New England Peptide Inc. in
Boston, MA. The amino acid sequence of hACTH(1-24), the analogs, and truncated
peptides used in this study can be found in Table 1.
Immunocytochemistry
For immunocytochemical experiments, the CHO cells were plated in 8-well
chamber slides at 2.5x104 cells per well. After 24 hours, the cells were transfected with 1
µg of the cDNA constructs by using Lipfectamine 2000 (Invitrogen, Carlsbad, CA) in an
OptiMEM medium (Madiateach Inc., Herndon, VA). Experiments were done on cells
transfected with xtMC2R V5 tagged cDNA alone or xtMC2R V5 tagged cDNA and
mMRAP1 Flag tagged cDNA. Transfected cells were incubated for 24 hours at 37ºC.
Next, the transfected CHO cells were fixed with a 4% PFA solution for 15 minutes, and
then all wells were washed with a 1xPBS solution. At this stage, half of the wells (4
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wells) were permeablized with a 0.3% Triton X-100 for 10 minutes, while the other 4
wells were left in the 1xPBS solution (unpermeablized). The primary antibodies, mouse
anti-V5 and the rabbit anti-FLAG, were used to detect the receptor and MRAP
respectively. It should be noted that both primary antibodies were diluted to 1:500, and
applied to the cells for 1 hour at 37ºC. After three washes with the 1xPBS solution, cells
were incubated with the respective secondary antibodies, donkey anti-mouse conjugated
with Alexa388 and donkey anti-rabbit conjugated with Alexa555, for the receptor and
MRAP respectively. These secondary antibodies were applied for 45 minutes at a 1:800
dilution. After another three washes with 1xPBS, chambers were removed from slides.
Coverslips were applied to the slides with Vecta-Shield from Vector Laboratories Inc.,
Burlingame, CA. Additionally, the nuclei were stained with DAPI (blue), and coverslips
were sealed with clear nail polish. The slides were imaged using a fluorescent Zeiss
Axioplan 2 microscope with a Hamamatsu digital camera. Finally, all slides were
observed using a 100x oil immersion objective. The immunocytochemical images were
analyzed using Slidebook software (www.slidebook.com). The negative control for the
immunocytochemical staining slides were non-transfected CHO cells that did not include
the cDNAs of interest to make sure that the CHO cells did not express receptor or
accessory protein endogenously.
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cAMP Reporter Assay (Luciferase Assay)
In the cAMP Reporter Assay, 2.5x106 cells/reaction were used (24 wells of a
white 96 wells plate = one reaction). It should be noted that 4 reactions could be
performed on a white 96 well plate. Cells were co-transfected with 2µg of the following
cDNA constructs: xtMC2R, mMRAP1, and CRE-Luciferase (Chepurny & Holz, 2007).
Transfections were done utilizing the Amaxa Cell Line Nucleofector II system (Lonza
Group, LTD, MD), 100 µl Solution T/reaction, and program U-23. After a 10 minute
period of recovery in 500 µl of CHO media, the transfected cells were diluted in 7.5 mL
of CHO media. It should be noted that the 600µL of reaction mixture should be mixed
well in the dilution media, so that the mixture is homogenous to plate 1x105 cells per well
(300µL per well). After about 24 hours of the transfection, cells were fed with 300 µL of
fresh CHO media.
On the third day of the Luciferase Assay, the transfected cells were stimulated
with hACTH(1-24) or hACTH(1-24) analogs. Using serum-free CHO Media (does not
contain FBS), serial dilutions were carried out with the wild type peptide or the analogs,
at concentrations ranging from 10-6 to 1012 M. In addition, each dose was tested in
triplicate. Then, the stimulated plate was incubated at 37ºC incubator for 4 hours. After
the 4 hour stimulation period, the plate was allowed to cool to room temperature, and the
stimulation solution was removed.. Next, a 1:1 ratio of serum free CHO media and
Luciferase substrate reagent Bright GLO (Promega, WI) was gently mixed in a 15 mL
conical tube. The Luciferase substrate solution was applied to each well (100 µL/well),
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and allowed to incubate at room temperature for 5 minutes. Finally, luminescence of each
well was measured using the Bio-Tek Syngergy HT plate reader (Winooski, VT).
Additionally, basal levels of cAMP production needed to be determined to
produce an accurate activation curve. Therefore, a negative control was included in each
assay where the transfected CHO cells were not stimulated with wild type ACTH(1-24)
or the analog peptides used in the experiment. The negative control was subtracted from
each data point, and the corrected data points for each dose response curve were fit to the
Michaelis-Menton equation to produce an EC50 value for each activation curve. These
activation curves were analyzed by using Kaleidograph software (www.syngery.com).
Statistical Analysis
Data points were calculated as a mean with standard error values that were
obtained from experiments performed in a triplicate. To determine statistical significance
between experimental treatments and their corresponding controls, an unpaired two-tailed
Student’s t-test for equal variance was calculated; significance was set at P ≤ 0.05.
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Figure 10: Two Dimensional Structure of Xenopus tropicalis MC2R

= normal amino acid sequence of xt.MC2R
= TM4 alanine substitution sites
= EC2 alanine substitution sites
= TM5 alanine substitution sites
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Table 1: Human ACTH(1-24) Wild Type Peptide and Analogs. The alanine
substitutions that have replaced amino acids in the peptide are underlined.
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Results
Immunocytochemistry of the Xenopus tropicalis MC2 Receptor and Mouse MRAP1
Several studies had shown that functional expression of mammalian MC2Rs in
heterologous mammalian cells, such as CHO cells, required co-expression with the
accessory protein, MRAP1 (Webb and Clark, 2010, Hinkle and Sebag, 2010). Would this
same restriction apply to other tetrapod MC2Rs? To initially address this question, an
immunofluorescence approach was used to determine whether a V5-epitope tagged
xtMC2R cDNA construct also required MRAP1 for trafficking to the plasma membrane.
As a control, non-transfected CHO cells were reacted with the V5 primary antiserum and
the V5 secondary antiserum (Figure 11A), and the cells were left non-permeabilized.
Note that no reaction was observed. This outcome indicated that the V5 antiserum did not
react with any polypeptides on the surface of non-transfected cells. In the next
experiment (Figure 11B), CHO cells were transfected with the V5-tagged xtMC2R
cDNA construct alone, and the immunofluorescence reaction was once again done on
non-permeablized cells. No reaction was observed. This outcome could indicate a
problem with the expression of the xtMC2R cDNA construct, hence the experiment was
repeated, but the transfected cells were permeabilized (Figure 11C). Note the intense
reaction in the cytoplasm of the transfected cells. Collectively, Figures 11B and 11C
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indicate that the CHO cells could express the V5-tagged xtMC2R cDNA construct, but
the receptor was not moving to the plasma membrane of the transfected cells.
In the next series of experiments (Figure 11D, E, F), CHO cells were co-transfected
with a V5-tagged xtMC2R cDNA construct and a Flag-tagged mouse MRAP1
(mMRAP1) cDNA construct. In these experiments the immunofluorescence reaction was
performed on non-permeabilized cells. Figure 11D indicates that the V5-tagged xtMC2R
can be clearly detected on the plasma membrane. Figure 11E indicates that the Flagtagged mMRAP1 could also be detected on the plasma membrane. Figure 11F shows the
immunofluorescence images merged, which is an indication that xtMC2R and mMRAP1
are in close proximity on the plasma membrane. Collectively, these experiments provided
the first evidence that an amphibian MC2R requires the presence of an MRAP1 to
facilitate trafficking to the plasma membrane. As a result, in all subsequent experiments
the xtMC2R cDNA construct was co-expressed with mMRAP1. Mouse MRAP1 was
used for functional assay experiments due to the fact that a X. tropicalis MRAP1 ortholog
had not been detected in the X. tropicalis genome project (web site for xt genome
project). The operating assumption was that tetrapod MC2Rs should be able to interact
with tetrapod MRAP1s. The following experiments supported this assumption.
The immunocytochemistry images (Figure 11) showed that the xtMC2R required
co-expression with an MRAP to facilitate trafficking to the plasma membrane. The next
question to address was whether xtMC2R could be functionally expressed in CHO cells;
that is, was it possible to show cAMP production when xtMC2R was co-expressed with
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mMRAP1? The CHO cell system was also used to determine whether MRAP2, a paralog
of MRAP1 had any effect on the activation of xtMC2R. These experiments utilized a
cAMP reporter gene (CRE/Luciferase construct; see Methods) to measure the amount of
cAMP produced following stimulation with human ACTH(1-24). The rationale for using
hACTH(1-24) was presented in the Introduction.
Figure 11: Xenopus Tropicalis MC2R and Mouse MRAP1 Immunocytochemistry
Images

Immunocytochemical analysis of the Xenopus tropicalis MC2 receptor. For these
experiments the xtMC2R receptor was tagged with a V-5 epitope and the mMRAP1 was
tagged with a FLAG epitope. In all of the experiments nuclei were stained with DAPI.
Permeabilized cells were pretreated with 0.3% Triton X-100 prior to application of the
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V5 primary antiserum. A) Non-permeabilized, non-transfected CHO cells were reacted
with the V5 antiserum. The arrow points to a DAPI stained nucleus. B) Nonpermeabilized CHO were transfected with xtMC2R cDNA construct only. The arrow
points to a DAPI stained nucleus. C) Permeablized CHO cells were transfected with the
xtMC2R cDNA construct only. The arrow points to fluorescence detected in the
ER/Golgi complex. D) Non-permeablized CHO cells were co-transfected with the
xtMC2R cDNA construct and mMRAP1 cDNA construct. This section was only reacted
with the V5 antiserum. The arrow points to FITC fluorescence on the surface of the
transfected cells. E) The same sections in “D” were reacted with Flag antiserum. The
arrow points to CY3 fluorescence on the surface of the transfected cells. F) Images from
“D” and “E” were merged and the co-localization of xtMC2R and mMRAP1 can be
visualized as a neon-orange color on the cell membrane (arrow).
Functional Expression of xtMC2R: Interactions with Mouse MRAP1 & 2
Figure 12 represents a collection of xtMC2R activation curves following stimulation
with hACTH(1-24). When xtMC2R was expressed along (red circles) there was no
evidence of a dose dependent increase in cAMP following stimulation with hACTH(124). However, when xtMC2R and mMRAP1 were co-expressed, stimulation with
hACTH(1-24) resulted in a dose dependent increase in cAMP production (blue squares).
The EC50 for this dose response curve was 1.7 x 10-9 M; a value very similar to the EC50
value reported by Liang et al. (2011).
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Although an ortholog of MRAP1 has not been found in the X. tropicalis genome,
an ortholog of MRAP2 has been found in this genome. Prior studies have shown that coexpression of mammalian MC2Rs with mammalian MRAP2 resulted in a weak response
when stimulated with ACTH(1-24) (Webb and Clark, 2010, Hinkle and Sebag, 2010). It
seemed worthwhile to repeat this experiment using xtMC2R. As shown in Figure 12
(green diamonds), co-expression of xtMC2R with mouse MRAP2 resulted in a weak
stimulation of the transfected cells only at a concentration of 10-6M. These results are
consistent with experiments done using mammalian MC2Rs (Hinkle and Sebag, 2010)
and experiments done by Liang et al. (20110 using X. tropicalis MRAP2. Collectively
these experiments indicate that tetrapod MRAP2s do not facilitate the activation of
tetrapod MC2Rs.
Figure 12: xtMC2R Co-Transfected with Mouse MRAP1 & 2

4 10

4

xt.MC2R
xt.MC2R + mMRAP1
xt.MC2R + mMRAP2

4

3.5 10

Cre-Luciferase Activity

3 10

4

4

2.5 10
2 10

4

4

1.5 10
1 10

4

5000
0
10

-12

10

-11

10

-10

10

-9

10

-8

[ACTH] M

35

10

-7

10

-6

This figure represents a collection of xtMC2R activation curves following stimulation
with hACTH(1-24); concentrations ranged from 10-6-10-12 M. CRE/Luciferase activity
was measured as reported in Methods. The red circles in the response of xtMC2R
expressed alone. Co-expression of xtMC2R and mMRAP1 (blue squares) resulted in a
dose dependent increase in activation curve (EC50 of 1.7 x 10-9 M). However, coexpression of xtMC2R and mMRAP2 (green diamonds) only showed a minimal
response at a ligand concentration of (10-6M). N = 3 for all experiments.
xtMC2R Stimulation with Human ACTH(1-24) or NDP-MSH
Previous studies had shown that mammalian MC2Rs could be activated by
mammalian ACTH(1-24) , but not by mammalian α-MSH (Schwyzer, 1977). This
outcome is puzzling given that both ACTH(1-24) and α-MSH have the HFRW motif (see
Introduction). These experiments were conducted to determine whether xtMC2R was
also exclusively selective for ACTH, but not α-MSH. In Figure 13, xtMC2R was
stimulated with NDP-MSH, an analog of α-MSH that is more potent than the native
hormone. In this experiment, the positive control was stimulation with hACTH(1-24) (red
circles; EC50 of 7.23 x 10-9 M). On the other hand, stimulation with NDP-MSH (α-MSH)
resulted in no activation (blue squares). Based on these observations, it would appear that
all tetrapod MC2Rs are exclusively selective for ACTH, but not α-MSH.
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Figure 13: Wild Type Xenopus tropicalis MC2R Stimulated with hACTH(1-24) or αMSH
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Stimulation of xtMC2R with hACTH(1-24) (red circles) or NDP-MSH (blue square) at
concentrations ranging from 10-6-10-12 M. Following hACTH(1-24) stimulation the EC50
value was 7.2 x 10-9 M. N = 3.
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XtMC2R: Human ACTH(1-24) Analog Studies
Prior to the characterization of the melanocortin-2 receptor as the “ACTH” receptor
on mammalian adrenal cortex cells (Mountjoy et al., 1992), a considerable number of
studies had been done on the structure/function relationship between mammalian ACTH
and the “ACTH” adrenal cortex receptor (i.e., melanocortin-2 receptor). As noted
previously, studies done in the 1970’s had established that the first twenty-four residues
of mammalian ACTH(1-39) had full biological activity (Schwyzer, 1977). In addition,
two domains in ACTH(1-24) were required for activation of the ACTH receptor (MC2R);
the H6F7R8W9 motif (Eberle and Schwyzer, 1975; Schwyzer, 1977) and the
K15K16R17R18P19 motif (Schwyzer, 1977; Costa et al., 2004; Liang et al., 2011). Finally,
several studies had demonstrated that α-MSH [NAc-ACTH(1-13)NH2] cannot activate
the “ACTH” receptor on mammalian adrenal cortex cells (Schwyzer, 1977; Buckley and
Ramachandran, 1981; Mountjoy et al., 1992).
More recently, the HFRW and KKRRP motifs in hACTH(1-24) were examined in
greater detail (Liang et al., 2013). In this study, hACTH(1-24) was divided into three
functional zones: A – H6F7R8W9; B – G10K11P12V13G14; C - K15K16R17R18P19 and single
alanine or multiple alanine analogs of hACTH(1-24) were synthesized (Table 1 in
Methods). The ability of these analogs to stimulate xtMC2R was tested by co-transfecting
CHO cells with xtMC2R and mMRAP1. Activation was measured using the
CRE/Luciferase cAMP reporter Assay. The positive control for these analog activation
studies was stimulation of xtMC2R by human ACTH(1-24).
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A) ACTH(1-24) Zone A Analogs: cAMP Assays
First, Zone A analogs (Table 1) were used to address the question of the relative
importance of each amino acid in the HFRW motif with respect to the activation of the
receptor. The results of these experiments are presented in Figure 14. The dose response
curve for the positive control of this experiment is represented by red circles. As
expected, the A4 (AAAA) analog was unable to activate the receptor (black triangle).
However, what was not expected was that incubation with either the AFRW, HARW,
HRAW, or the HFRA analogs also resulted in no stimulation at ligand concentrations of
10-7M and lower. The AFRW and the HRAW analogs did produce a slight stimulation at
the 10-6M concentration. These results are summarized in Table 2. Given the dose
response curves presented in Figure 14, it was not possible to calculate EC50 values for
any of the Zone A. analogs. It would appear that all of the positions in the HFRW motif
are equally crucial for activation of xtMC2R. It should be noted that the Zone A
stimulation results for xtMC2R are in sharp contrast to an earlier study on the human
MC2 receptor (Liang et al. 2013). The differences in the responses of the two receptors to
the Zone A analogs will be evaluated in the Discussion.
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Figure 14: Wild Type Xenopus tropicalis MC2R & Human ACTH(1-24) Zone A
Analogs
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This figure represents a collection of activation curves that resulted when xtMC2R was
incubated with various Zone A analogs of human ACTH(1-24). Dilutions of analogs
ranged from 10-6-10-12 M. Activation curves for the wild type hACTH(1-24) (red circles),
the AFRW analog (orange right triangles), the HARW analog (blue squares), the HFAW
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analog (green diamonds), the HFRA analog (pink squares), and the A4 analog (black
triangles) are presented. N = 3.
B) ACTH(1-24) Zone C Analogs: cAMP Assays
Past studies on the human MC2 receptor have indicated that the binding of
KKRRP motif of hACTH(1-24) is a critical first step in the activation of hMC2R (Liang
et al., 2013). In order to determine whether this same motif in hACTH(1-24) is also
essential for the activation of xtMC2R, three Zone C analogs were analyzed (Figure 15).
The positive control for these experiments was xtMC2R stimulated with hACTH(1-24).
The Zone C analogs were: A5 (A15 A16 A17 A18 A19), KKAAA, and AARRP, and
the EC50 values for these analogs are presented in Table 2. As shown in Figure 15, there
was no stimulation following incubation of xtMC2R with the A5 analog at any of the
concentrations tested (black triangles). In addition, incubation of xtMC2R with either the
KKAAA analog or the AARRP analog did not result in any stimulation at analog
concentrations of 10-7M or less. However, there was minor stimulation at the 10-6M
concentration. As a result of the weak activation at the highest concentration of ligand it
was possible to generate estimates of the EC50 values for the KKAAA and AARRP
experiments. The estimated EC50 value for the KKAAA analog was 3.7 x 10-6 M; a 512
fold shift in activation as compared to the positive control (Table 2). The estimated EC50
value for AARRP analog was 5.0 x 10-6 M; a 692 fold shift in stimulation as compared to
the positive control (Table 2). It would appear that KKRRP motif of ACTH(1-24) is
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required for the activation of xtMC2R. The role this motif may play in the activation
process will be considered in the Discussion.

CRE-Luciferase Activity

Figure 15: Wild Type X. tropicalis MC2R & Human ACTH(1-24) Zone C Analogs
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This figure represents a collection of activation curves that resulted when xtMC2R was
incubated with various Zone C analogs of human ACTH(1-24). Dilutions of analogs
ranged from 10-6-10-12 M concentrations. For the positive control xtMC2R was stimulated
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with hACTH(1-24) (red dots). The results of stimulating with the A5 analog (blue
squares), KKAAA analog (green diamonds), and the AARRPP analog (black triangles)
are presented. N = 3.
C) ACTH(1-24) Zone B Analogs: cAMP Assays
While it was expected that both Zones A and C in hACTH(1-24) have roles in the
activation of xtMC2R, it seemed appropriate to determine whether the Zone B motif
(GKPVG) also has a role in the activation process. The GKPVG motif in ACTH(1-24) is
highly conserved among the gnathostome vertebrates, and only a single amino acid
difference (M13 for V13) has been observed in gnathostomes ranging from the
cartilaginous fishes to mammals (Dores and Baron, 2011). A recent study on human
MC2R indicated that the Zone B motif may play a role in the positioning of the HFRW
and KKRRP motifs of ACTH(1-24) into their proposed binding sites on the receptor
(Liang et al, 2013). That study indicated that while single or double alanine substitutions
in the Zone B motif had no effect on activation, replacement of all residues in this motif
with alanines had a significant effect on activation (Liang et al, 2013). The following
experiments were done to determine if xtMC2R responded in a similar manner to the
Zone B alanine analogs.
Figure 16 presents a collection of activation curves that evaluated the effects of
Zone B analogs on the stimulation of xtMC2R. For the positive control for this
experiment (red circles), xtMC2R was stimulated with hACTH(1-24). Incubation with
the A10-14 (AAAAA; blue squares), did not result in any stimulation of the receptor at
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ligand concentrations tested at 10-7M or less. There was slight stimulation at a ligand
concentration of 10-6M. Similar results were observed when this analog was used to
stimulate human MC2R (Liang et al., 2013). Although this analog shows some cAMP
production, the response proved to be too weak, and therefore, no EC50 could be
calculated for A10-14 (Table 2). For the A10/14 analog the two glycines at
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Figure 16: Wild Type Xenopus tropicalis MC2R & Human ACTH(1-24) Zone B
Analogs

CRE-Luciferase Activity
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This figure represents a collection of activation curves based on cAMP production due to
the stimulation of xt.MC2R with Zone B analogs of human ACTH(1-24). Dilutions of
analogs ranged from 10-6-10-12 M. The positive control, xtMC2R, was stimulated with
hACTH(1-24) (red dots). The results of stimulating with A10-14 analog (blue squares),
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the KP (green diamonds), the P12 (black right-triangles), and the A10/14 analog (pink
squares) are shown, N = 3.

positions 10 and 14 were each replaced with an alanine residue (Table 1). While a dose
response curve was generated by this analog (pink-white squares), there was a significant
decrease in cAMP production relative to the positive control (p = 0.01), and a 25 fold
change in the EC50 value (1.8 x 10-7 M; p < 0.02) relative to the positive control (Table
2).
For the KP analog, alanine substitutions were done at K11 and P12 (green
diamonds). The KP analog generated a dose response curve with an EC50 value of 3.1 x
10-7 M (Table 2). This is a 43 fold shift in sensitivity for the ligand (Table 2). The t-test
for this EC50 value relative to the control was p < 0.00003 (Table 2). Therefore, these
results indicate that K11 and P12 play a role in the activation of the receptor.
The P12 analog (alanine substitution at position 12) generated a dose response
curve (black right-triangles) with an EC50 value of 5.6 x 10-8 M (Table 2). This is an 8fold shift in EC50 value relative to the positive control, and this shift was statistically
significant (p < 0.007). Overall, the hierarchy of crucial amino acid positions at Zone B
for activation of xtMC2R based on EC50 values was : A10-14>A10/14>KP>P.
D) ACTH(1-24) Zone B Truncated Analogs: cAMP Assays
The working hypothesis is that the Zone B motif is required for the proper
positioning of the HFRW motif and the KKRRP motif of ACTH(1-24) into
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corresponding binding sites on the receptor. The next experiments asked the question of
whether analogs of ACTH(1-24) shortened in the Zone B motif can stimulate the
receptor. The analogs, ACTH(1-21) and ACTH(1-22), were made to address this
question.
Figure 17: Wild Type Xenopus tropicalis MC2R & Human ACTH Truncated
Analogs
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This figure represents a collection of activation curves based on cAMP production due to
the stimulation of xt.MC2R with Zone B analogs of human ACTH(1-24). Dilutions of
analogs ranged from 10-6-10-12 M. The positive control, xtMC2R was stimulated with
hACTH(1-24) (red dots). The results of stimulating with ACTH(1-21) analog (blue
squares) and ACTH(1-22) analog (green diamonds) are shown, N = 3.
The first analog, ACTH(1-21) was shortened by removing amino acid positions
11, 12, and 13 (Lysine-Proline-Valine) from Zone B (Table 2). The second analog,
ACTH(1-22), was shortened by removing amino acid positions 10 and 14, which were
glycine residues at positions 10 and 14 (Table 2). Figure 17 presents the results of
stimulating xtMC2R with these truncated analogs. As indicated in the figure neither
analog was able to stimulate the receptor at ligand concentrations ranging from 10-12M to
10-6M (Table 2). Clearly, the length of ACTH(1-24) plays a role in the activation of the
receptor.
The results of the alanine analog studies have been used to create a proposed
mechanism for the activation of xtMC2R. This model will be presented in the Discussion
section.
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Table 2: Human ACTH(1-24) Analog EC50 and P Values
Analogs

Amino Acid Sequence

EC50 ± SEM
(10-9 M)

Fold
Change

P-Value

ACTH(1-24)
A4
AFRW
HARW
HFAW
HFRA
A10-14
AKPVA
GAAVG
GKAVG
ACTH(1-22)
ACTH(1-21)
A5
AARRP
KKAAA

SYSMEHFRWGKPVGKKRRPVKVYP
SYSMEAAAAGKPVGKKRRPVKVYP
SYSMEAFRWGKPVGKKRRPVKVYP
SYSMEHARWGKPVGKKRRPVKVYP
SYSMEHFAWGKPVGKKRRPVKVYP
SYSMEHFRAGKPVGKKRRPVKVYP
SYSMEHFRWAAAAAKKRRPVKVYP
SYSMEHFRWAKPVAKKRRPVKYVP
SYSMEHFRWGAAVGKKRRPVKVYP
SYSMEHFRWGKAVGKKRRPVKVYP
SYSMEHFRW-KPV-KKRRPVKVYP
SYSMEHFRWG---GKKRRPVKVYP
SYSMEHFRWGKPVGAAAAAVKVYP
SYSMEHFRWGKPVGAARRPVKVYP
SYSMEHFRWGKPVGKKAAAVKVYP

7.23 ± 3.2
NA
NA
NA
NA
NA
NA
180 ± 61*
310 ± 17***
56 ± 12*
NA
NA
NA
3700 ± 3900
5000 ± 1400*

--------------24.8
42.8
7.7
------511.7
691.6

--------------0.02
0.00003
0.007
------0.2
0.01

***Human ACTH(1-24) Analog Zones = Zone A, Zone B, Zone C This table represents
human ACTH(1-24) analogs in Zones A, B, and C. Each ligand is shown with its alanine
substitution(s) at the respective position(s) while the wild type hACTH(1-24) is shown as
the first ligand. It should be noted that the EC50 of the standard curve is a mean of all wild
type ACTH(1-24) standard activation curves. Experimental EC50 values are reported, and
were standardize at 10-9 Molar. If a ligand did not receive a calculated EC50 value, the
ligand was reported as causing no activation (NA). The fold change of ACTH(1-24)
analogs was reported for experimental EC50 values that were found to be of significance.
Fold change = (Experimental EC50 value ÷ Standard EC50 value). If the analog’s EC50
value was found to be significantly different than the mean positive standard EC50 value,
p-values were reported to suggest statistical significance (*: p-value < 0.05; **: p-value
<0.005; ***: p-value < 0.0005).
xtMC2R Alanine Mutant Studies: TM4, EC2, and TM5 Regions
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As noted, there is general agreement that the HFRW binding site in all
melanocortin receptors involved amino positions located close to the surface in TM
regions 2, 3, 6, and 7 (Pogosheva et al. 2005; Baron et al. 2008; Dores, 2009; Dores,
2013; Davis et al., 2013). The model presented in Figure 18 shows the relative position of
HFRW binding site (TM regions in blue) and served as a reference point for the operating
assumption that the KKRRP binding site would involve amino acid positions possibly in
TM 4, extracellular loop 2 (EL2) or TM5.

(Lisa Liang 2013 Ph.D. Thesis) On the “barrel” diagram the blue shaded areas indicate
the location of the HFRW binding site, and the yellow shaded areas indicated the
proposed location of the KKRRP binding site. In the linear diagram the positions that
were targeted for alanine substitution are in color (red – TM2; green EL2; blue TM5).
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In the initial experiments, all the amino acid positions in the respective colored
regions (Figure 18; linear image of the receptor) were substituted with alanine residues.
This resulted in three mutant receptors that were labeled X1 (TM4 mutant), X2 (EL2
mutant), and X3 (TM5 mutant), respectively. These mutant receptors were individually
stimulated with hACTH(1-24). In these experiments (Figure 19), the wild type xtMC2R
(black circles) was also stimulated with hACTH(1-24) and served as the positive control.
Stimulation of the X1 mutant receptor (TM4 region; blue squares) resulted in a significant
decrease in cAMP production. The estimated EC50 value for this dose response curve was
1.60 x 10-7M and resulted in a 168-fold shift in the EC50 value relative to the positive
control (Table 3; p < 0.01). The X2 mutant (EL2 region; green diamonds) did not show
any signs of activation. Therefore, an EC50 value for this mutant receptor could not be
calculated (Table 3). Stimulation of the X3 mutant receptor (TM5 region; red triangles)
resulted in a slight production of cAMP. The X3 mutant receptor had an estimated EC50
value of 3.7 x 10-8 M; a 34-fold shift in EC50 value as compared to the positive control
(Table 2). Although these results were suggestive, the presence of so many alanine
residues in each of these mutants could have altered confirmation, and as a result affected
trafficking of the mutant receptor to the plasma membrane. Hence, the next approach was
to do single alanine substitutions in each targeted region.
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Figure 19: Xenopus Tropicalis MC2R TM4, EC2, and TM5 (X1, X2, and X3) Regions
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with Complete Alanine Substitutions
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This figure represents a collection of mutant xtMC2R activation curves with multiple
alanine substitutions in the TM4, EL2, and TM5 regions of the receptor. The TM4, EL2,
and TM5 were abbreviated as X1, X2, and X3 respectively. The X1, X2, and X3 mutant
were all stimulated with hACTH(1-24). Dilutions of hormone ranged from 10-6-10-12 M.
The wild type xtMC2R is shown in black circles. The X1 mutant receptor (TM4: blue
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squares) had a deceased response to hormone stimulation, and the estimated EC50 value
for this dose response curve was 1.6 x 10-8 M (Table 3). The X2 mutant receptor (EC2;
green diamonds) did not show any activation. The X3 mutant receptor (TM5; red
triangles) showed a slight activation at 10-7M and 10-6M. The estimated EC50 value for X3
mutant receptor was 3.7 x 10-8 M (Table 3).
A) Transmembrane 4 Domain (TM4): Single Alanine Mutant Assays
The activation dose response curves for the single alanine mutants of the TM4
region are presented in Figures 20 and 21. The EC50 values and the fold shift in EC50
values relative to the positive control for these single alanine mutant receptors are
presented in Table 3. In Figure 20, the dose response curves for the single alanine
mutants at amino acid positions G171, I172, and A173 are presented. For the A173 mutant a
glutamine residue was used. All three receptors had EC50 values that were statistically
different from the positive control (Table 3). However, there was only a threefold change
for the G/A171 mutant, and this change is not considered significant. There was a 8 fold
change for the I/A172 and this is a mild, but not dramatic shift in EC50. However, the
A/Q173 mutant had a 55 fold shift in EC50 value, and this outcome was initially
unexpected. Alanine substitution is the most common approach used in this type of study
because alanine residues are generally considered to be place holder residues. The Rgroup for this amino does not interact with other amino acid R-groups, hence we assumed
this position would not be involved in the receptor activation process. However, by
substituting a glutamine residue, an amino acid with a much larger and more reactive R53

group, we suspect that we have interfered with the role that neighboring amino acids may
play in the activation process.
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Figure 20: Xenopus Tropicalis TM4 Mutant Receptors G171, I172, & A173
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Dose response curves for G171, I172, and A173 mutants in the TM4 region of the receptor.
The mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from
10-6-10-12 M. The dose response curve for the wild type xtMC2R is shown in red circles.
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The dose response curves for the G171 mutant (blue squares), the I172 mutant (green
diamonds), and the A173 mutant (black triangles) are presented. N = 3.
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Figure 21: Xenopus Tropicalis TM4 Mutant Receptors I174 & I175
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Dose response curves for the I174 and I175 mutants in the TM4 region of the receptor. The
mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 10-610-12 M. The dose response curve for the wild type xtMC2R is shown in red circles. The
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dose response curves for the I174 mutant (blue squares) and the I174 mutant (green
diamonds) are presented. N = 3.
In Figure 21 the dose response curves for the single alanine mutants at amino acid
positions I174 and I175 are presented. The EC50 values for this mutant receptor are
presented in Table 3. The EC50 value for the I/A174 was only three fold and not considered
significant. However, the I/A175 mutant had an EC50 value that resulted in a 284.2 fold
shift relative to positive control. This amino acid position is clear important for the
activation of xtMC2R. In addition it is possible that the A/Q173 mutant may have partially
interfered with I174.
B) Extracellular Loop 2 (EL2): Single Alanine Mutants Assays
The activation dose response curves for the single alanine mutants of the EL2 region
are presented in Figures 22, 23, 24, and 25. The EC50 values and the fold shift in EC50
values relative to the positive control for these single alanine mutant receptors are
presented in Table 3.
In Figure 22 the dose response curves for the single alanine mutants at amino acid
positions M176, L177, and T181 are presented. The EC50 values for the M176, L177, and T181
mutants were not significantly different from the positive control (Table 3); hence these
positions do not appear to be involved in the activation of the receptor.
In Figure 23 the dose response curves for the single alanine mutants at amino acid
positions F178 and A182 are present. For the A182 mutant a glutamine residue replace A182.
Activation of the F/A178 mutant was affected as a result of the alanine substitutions, there
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was an 83 fold shift in the EC50 value (Table 3) as a result. Not only does the EC50 value
indicate receptor insensitivity, the Vmax for F/A178 mutant indicates a significant decrease
in cAMP production. In addition, the A/Q182 mutant also clearly interfered with the
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Figure 22: Xenopus Tropicalis EC2 Mutant Receptors T181, L177, and M176
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Dose response curves for the M176, L177, and T181 mutants in the EL2 region of the
receptor. The mutant receptors were all stimulated with hACTH(1-24) at dilutions
ranging from 10-6-10-12 M. The dose response curve for the wild type xtMC2R is shown
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in red circles. The dose response curves for the M176 mutant (black triangles), L177 (green
diamond), and the T181 mutant (blue squares) are presented. N = 3.
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Figure 23: Xenopus Tropicalis EC2 Mutant Receptors A182 & F178
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Dose response curves for the F178 and A182 mutants in the EL2 region of the receptor. The
mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 10-610-12 M. The dose response curve for the wild type xtMC2R is shown in red circles. The
dose response curves for the F178 mutant (green triangles) and the A182 mutant (blue
squares) are presented. N = 3.
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activation of the receptor. It is possible that substitution at this site may have affected
either H179 or M183 (see Table 3).
In Figure 24 the dose response curves for the single alanine mutants at amino acid
positions H179, D180, and I184 are presented. Substitution at H179 had a minimal impact on
the activation of the receptor (Table 3). However, the dose response curve for the D/A180
mutant resulted in an EC50 value with a 40 fold shift relative to the positive control (Table
3). The dose response curve for the I/A184 mutant was even more dramatic. This mutant
had an EC50 value with 495 fold shift relative to the positive control (Table 3). The I184
position is clearly the most important site for interaction with the KKRRP region of
ACTH(1-24).
In Figure 25 the dose response curves for the single alanine mutants at amino acid
positions M183 and I185 are presented. The I/A185 mutant generated a dose response curve
with an EC50 value that resulted in a 2 fold shift relative to the positive control (Table 3).
Substitution at this site does not appear to significantly affect the activation of the
receptor. However, the M/A183 mutant generated a dose response curve with an EC50
value that resulted in a 22 fold shift relative to the control (Table 1), and this position is
considered important for the activation of the receptor.
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Figure 24: Xenopus Tropicalis EC2 Mutant Receptors H179, I184, & D180
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Dose response curves for the H179, D180, and I184 mutants in the EL2 region of the
receptor. The mutant receptors were all stimulated with hACTH(1-24) at dilutions
ranging from 10-6-10-12 M. The dose response curve for the wild type xtMC2R is shown
in red circles. The dose response curves for the H179 mutant (blue squares), D180 (black
squares), and the I184 mutant (green squares) are presented. N = 3.
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Figure 25: Xenopus Tropicalis EC2 Mutant Receptors M183 & I185
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Dose response curves for the M183 and I185 mutants in the EL2 region of the receptor. The
mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from 10-610-12 M. The dose response curve for the wild type xtMC2R is shown in red circles. The
dose response curves for the M183 mutant (blue squares) and the I185 mutant (green
diamonds) are presented. N = 3.
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C) Transmembrane 5 Domain: Single Alanine Mutant Assays
The activation dose response curves for the single alanine mutants of the TM5 region
are presented in Figures 26, 27, and 28. The EC50 values and the fold shift in EC50 values
relative to the positive control for these single alanine mutant receptors are presented in
Table 3. In Figure 26 the dose response curves for the C186 and L187 mutants are
presented. In Figure 27 the dose response curves for the T188, V189, and M190 mutants are
presented. In Figure 28 the dose response curves for the F191 and L192 mutants are
presented. As indicated in Table 3, none of these mutants had dose response curves with
EC50 values greater that 4 fold relative to the positive control with the exception of L/A187
mutant (6.5 fold change). Based on these observations it appears that region of the
receptor is not important for the activation of the receptor.
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Figure 26: Xenopus Tropicalis TM5 Mutant Receptors C186 & L187
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Dose response curves for the C186 and L187 mutants in the TM5 region of the receptor.
The mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from
10-6-10-12 M. The dose response curve for the wild type xtMC2R is shown in red circles.
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The dose response curves for the C186 mutant (blue squares) and the L187 mutant (green
diamonds) are presented. N = 3.
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Figure 27: Xenopus Tropicalis TM5 Mutant Receptors T188, V189 & M190
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Dose response curves for the T188, V189, and M190 mutants in the TM5 region of the
receptor. The mutant receptors were all stimulated with hACTH(1-24) at dilutions
ranging from 10-6-10-12 M. The dose response curve for the wild type xtMC2R is shown
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in red circles. The dose response curves for the T188 mutant (blue squares), V189 mutant
(green diamonds), and the M190 mutant (black squares) are presented. N = 3.
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Figure 28: Xenopus Tropicalis TM5 Mutant Receptors F191 & L192
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Dose response curves for the F191 and L192 mutants in the TM5 region of the receptor.
The mutant receptors were all stimulated with hACTH(1-24) at dilutions ranging from
10-6-10-12 M. The dose response curve for the wild type xtMC2R is shown in red circles.
The dose response curves for the F191 mutant (blue squares) and L192 mutant (green
diamonds), are presented. N = 3.
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Table 3: Xenopus tropicalis TM4, EC2, and TM5 Mutant Receptor EC50 Value and
P-Values
Amino Acid

EC50 (10-9M)

Fold Change

P-Value

Wild Type

0.95 ± 0.44

---

---

X1

160 ± 49*

168.4

0.01

X2

NA

---

---

X3

37 ± 29

34

0.1

G171
I172

2.8 ± 0.62**
8.3 ± 0.31***

3.0
8.7

0.0008
0.00008

A173

52.4 ± 4.76***

55.2

0.0002

I174

2.8 ± 0.66**

3.0

0.001

I175

270.0 ± 72***

284.2

0.0002

M176

0.8 ± 0.09

0.8

0.8

L177

0.98 ± 0.11

1.0

0.4

F178

79.0 ± 14***

83.2

0.00004

H179

2.9 ± 0.87**

3.1

0.002

D180

38.0 ± 8.6***

40

0.0001

T181

0.72 ± 0.17

0.7

0.9

A182

14.0 ± 1.1***

14.7

0.0002

M183

22.0 ± 1.8***

23.2

0.0002

I184

470.0 ± 240**

494.7

0.002

I185

2.0 ± 0.93*

2.1

0.02

C186

3.5 ± 1.1**

3.7

0.001

L187

6.2 ± 1.04***

6.5

0.00008

T188

0.5 ± 0.07

0.5

0.9

V189

2.4 ± 1.4*

2.5

0.02

M190

2.2 ± 0.44**

2.3

0.002

F191

1.62 ± 0.42*

1.1

0.01

L192

0.75 ± 0.3

0.8

0.8

This table includes all EC50 values for the xt.MC2R TM4, EC2, and TM5 region mutant
receptors where single alanines substituted corresponding amino acid positions of the
xt.MC2R. Also, the EC50 for complete alanine substitution of TM4, EC2, and TM5
regions were inserted at the top of the table. The fold change of the mutant receptors
compared to the mean EC50 value of the standard curve was calculated as Fold Change =
mutant receptor EC50 value ÷ standard EC50 value. Also, a Student’s T Test was used to
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observe if mutant receptor EC50 value was different than standard EC50 value. If the
comparison of the two EC50 values differed drastically, the mutant receptor would be
designated as significant. Therefore, significance would of the experimental EC50 value
would be assigned a p-value ≤ 0.05 (*: p-value < 0.05; **: p-value < 0.005; ***: p-value
< 0.005)
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Discussion
Tetrapod and Teleost MC2Rs: MRAP1 Requirement and Ligand Selectivity for ACTH
This study on the melanocortin-2 receptor of the amphibian, Xenopus tropicalis
(xtMC2R), adds to the growing literature on teleost and tetrapod MC2Rs, and provides
additional evidence that among teleost and tetrapod MC2Rs there are a number of
universal features. First, teleost and tetrapod MC2Rs can only be activated by ACTH
(for review see Dores, 2013). In this regard, only the ACTH(1-24) sequence is required
for full activation of teleost or tetrapod MC2R. Second, teleost and tetrapod MC2Rs
require an intimate interaction with MRAP1 in order to not only move from the ER to the
plasma membrane, but also for activation following an ACTH binding event. The
corollary to this statement is that it appears that tetrapod MC2Rs require interaction with
tetrapod MRAP1, and teleost MC2Rs require interaction with a teleost MRAP1 to
achieve functional activation (Liang et al., 2011).
With regard to the MC2R expression requirements, the results of this study
showed that xtMC2R cannot be functionally expressed without interaction with a
mammalian MRAP, (i.e., mouse MRAP1; Figure 12). Although it is hypothesized that an
xtMRAP1 homolog exists in the Xenopus tropicalis genome, this accessory protein gene
has yet to be identified. Therefore for the studies presented in this thesis, mouse MRAP1
(mMRAP1) was used to functionally express xtMC2R on the plasma membrane of CHO
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cells. However, genomic screening has detected a homolog of the MRAP2 gene in the X.
tropicalis genome. Past studies have shown that xtMC2R can be activated by xtMRAP2
in the CHO cell functional assay system. However, activation was only shown at the
highest concentration of hACTH(1-24) tested (i.e., 10-6M; Liang et al., 2011). Similar
results were observed in Figure 12 when an ortholog of MRAP2 (mMRAP2) was coexpressed with xtMC2R.
With regard to ligand selectivity, several studies have shown that mammalian
MC2Rs cannot be activated by α-MSH ((Buckley and Ramachandran, 1981; Mountjoy et
al.,1992; Schwyzer,1997). As previously noted, the α-MSH amino acid sequence is
positioned within the ACTH(1-39) amino acid sequence (Figure 4B). This thesis showed
that while xtMC2R can be activated by ACTH(1-24) (Figure 13), this receptor cannot be
activated by α-MSH (Figure 13). Given the sequence relationship between α-MSH and
ACTH, these observations support the hypothesis that tetrapod MC2Rs interact not only
with the HFRW motif in ACTH. But also with another site in ACTH (Schwyzer, 1977),
and correspondingly, the melanocortin-2 receptor must have multiple binding sites for
ACTH. In support of these conclusions a recent study indicated that the MC2R ortholog
of the reptile, Anolis carolinensis, also required co-expression with mMRAP1 when
expressed in CHO cells, and the reptile receptor could be activated by ACTH(1-24), but
not by α-MSH (Davis et al., 2013).
The arguments for expanding the ligand selectivity and MRAP1 requirements of
MC2R to include teleost MC2Rs, come from studies on the zebrafish, Danio rerio
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(Agulleiro et al., 2010), the rainbow trout, Oncorhynchus mykiss (Aluru and Vijayan,
2008; Liang et al., 2011), and the sea bass, Dicentrarchus labrax , (Aquilleiro et al.,
2013). In these studies, the functional expression of the teleost MC2R in heterologous
mammalian cell lines required co-expression with a teleost MRAP1. In addition, ligand
selectivity studies confirmed that while the teleost MC2Rs could be activated by
hACTH(1-24), these melanocortin receptors did not respond to stimulation by α-MSH.
Hence, it appears that among the bony vertebrates (i.e., modern bony fishes, amphibians,
reptiles, birds, and mammals), MC2R is MRAP1 dependent, and insensitive to α-MSH.
These conclusions are summarized in Figure 29.
Do these conclusions apply to all gnathostomes? The cartilaginous fishes,
together with the bony vertebrates constitute Superclass Gnathostoma (Nelson, 1994).
Recently an ortholog of MC2R has been detected in the genome of the cartilaginous fish,
Callorhinchus milii (the elephant shark; Vastermark and Schioth, 2011). Studies on the
elephant shark MC2R indicate that this receptor is MRAP1 independent and the receptor
can be activated by both ACTH(1-24) and α-MSH (Reinick et al., 2012). Similar results
have been observed for the MC2R ortholog in the genome of the sting ray, Dasyatis
akajei (R.M. Dores, unpublished data).
Collectively, these observations have led to the following evolutionary hypothesis
(Figure 29; Dores, 2013). During the emergence of the ancestral gnathostomes
(approximately 480 MYA), the melanocortin-2 receptor was MRAP1 independent, and
the receptor could be activated by both ACTH and α-MSH. These properties appear to be
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retained in the cartilaginous fishes. Following the divergence of the ancestral
cartilaginous fishes, and the ancestral bony fishes, mutations occurred in the MC2R gene
in the bony fish lineage. These mutations resulted in the exclusive selectivity of MC2R
for ACTH, but these changes also led to the dependence on MRAP1 for the functional
expression of MC2R. The ramifications of these mutations will be discussed in a later
section of this Discussion.
Figure 29: Phylogeny of MC2R Ligand Selectivity and Interaction with MRAP
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Tetrapod and Teleost ACTH(1-24) Analog Studies
Prior studies have shown that ACTH(1-24) is the functional region of ACTH(139). These studies had also proposed that this functional region consists of two motifs
that are essential for the activation of mammalian MC2R: the HFRW motif and KKRRP
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motif (Eberle and Schwyzer, 1975; Schwyzer, 1977). Do these same requirements apply
to other tetrapod MC2Rs such as X. tropicalis MC2R? Would these same requirements
apply to a teleost MC2R? To address these questions this thesis analyzed the effect of
introducing alanine substitutions into hACTH(1-24), and testing the effects of these
analogs on the functional activation of xtMC2R. Another thesis project (Lisa Liang,
2013) conducted a parallel study on rainbow trout MC2R. The analogs that were tested
were divided into three zone (A, B, C) as shown in the Methods (Table 1), which
corresponded to the H6F7R8W9 motif, the G10K11P12V13G14 motif, and the
K15K16R17R18P19 motif, respectively.
Before discussing the results of the Zone A (HFRW) analog studies, it should be
noted that all melanocortin peptides have the HFRW motif (Schwyzer, 1977), and
conversely, the activation of all melanocortin receptors is dependent on the binding of
this motif on the ligand to the receptor. Is there a common HFRW binding site on all
melanocortin receptors? Pogosheva et al (2005) initially addressed this question by
performing a modeling study and site directed mutagenesis study on the human
melanocortin-4 receptor (hMC4R). That study identified critical amino acid positions in
TM 2, 3, 6, and 7 that are required for interacting with the HFRW motif of α-MSH.
Those amino acid positions are shown in Figure 30A. Interestingly these same positions
are nearly universally conserved in the MC1R, MC3R, MC4R, and MC5R paralogs of
teleosts and tetrapods (Dores, 2009; Baron et al., 2009). Does xtMC2R have these critical
positions? As shown in Figure 30B, nine of the twelve critical amino acid positions are
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identical in xtMC2R and hMC4R. If the analysis is expanded to include human MC2R
and rainbow trout MC2R, six of the positions are identical in all four sequences.
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Analysis of Zone A Analogs of hACTH(1-24)
As presented in the Results, there were five Zone A analog (HFRW analogs): A4
(AAAA), AFRW, HARW, HFAW, and HFRA. As expected, the A4 analog was unable
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to stimulate activation at any concentration tested. These results were not surprising.
However, it was unclear at the start of these experiments how single alanine substitutions
would affect the activity of the Zone A analogs. Initially the analogs were tested on the
hMC4R expressed in CHO cells (Liang et al., 2013). For hMC4R, the order of
importance of the amino acid positions in the HFRW motif was W>>R=F>H.
Substitution at the W9 completed blocked stimulation of hMC4R, whereas substitution at
ether F7or R8 shifted the EC50 value 15,000 fold relative to the positive control, and
substitution at the H6 resulted in 100 fold shift in EC50 value relative to the control. When
these same analogs were tested on human MC2R, the order of ligand importance was
W>>F>R>H (Liang et al., 2013). Once again substitution at W9 completely blocked
activation of hMC2R. However, substitutions at F7, R8, and H6 resulted in shifts in EC50
values of 8000 fold, 4000 fold, and 9 fold respective. Clearly, hMC4R and hMC2R did
not respond to the Zone A analogs to the same degree. While the W9 position is clearly
essential for both receptors, substitution at the other positions produced receptor-specific
responses. These outcomes can be partially explained by the subtle differences in primary
sequence at HFRW binding sites of the two receptors (Figure 29).
When these same single alanine Zone A analogs were tested on xtMC2R, there
was no activation of the receptor following incubation with either the HARW analog or
the HFRA analog (Table 2). In addition, only slight activation was observed at a
concentration of 10-6 M following incubation with the HFAW analog and AFRW analog
(W=F>>R=H). Clearly primary sequence differences at the critical positions in the
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HFRW binding site (Figure 30) appear to make xtMC2R much less tolerant of alanine
substitutions to hACTH(1-24) than hMC2R. It would be reasonable to speculate that the
3-dimensional shape of the HFRW binding site in xtMC2R and hMC2R may be similar,
but definitely not identical.
When these same single alanine Zone A analogs were used to stimulate the
rainbow trout MC2R (rtMC2R), yet another pattern was observed with the respect the
order amino acid position importance. For rtMC2R the order was W=R>F>H (Lisa
Liang, Ph.D. thesis, 2013). For the rtMC2R, incubation with the HFRA analog actually
resulted in a dose dependent stimulation at 10-7M and 10-6M. This level of stimulation
was not observed for hMC2R, hMC4R, or xtMC2R. In addition, substitution at H6 had no
negative effect on activation; the EC50 value for the AFRW analog was not statistically
different from the positive control (Lisa Liang, Ph.D. thesis, 2013). Collectively, these
observations lend support to the conclusion that while an HFRW binding site is a
common feature of all melanocortin receptors, there appears to be differences in the 3dimension structure of this site even between orthologs. Molecular modeling approaches
are needed to resolve these shape differences.
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Analysis of Zone C Analogs of hACTH(1-24)
The role of the KKRRP motif (Zone C) in ACTH(1-24) as the “address” motif
required for initial interaction with the “ACTH” receptor (aka MC2R) was initially
proposed by Schwyzer (1977). Analogs of this region included A5 (A15A16A17A18A19),
A15A16RRP, and KKA17A18A19. As shown in Figure 15 there was no stimulation of
xtMC2R following incubation with the A5 analog at any of the concentrations tested. The
same outcome was observed when the A5 analog was tested on rtMC2R (Lisa Liang,
Ph.D. Thesis, 2013). However, incubation of the hMC2R with the A5 analog resulted in a
dose dependent increase in cAMP production at concentrations of 10-8M and 10-7M.
In addition, incubation of xtMC2R with the analogs, AARRP and KKAAA,
resulted in diminished activation of xtMC2R, and the EC50 values for these analogs were
5.0 x10-6 M and 3.7 x 10-6 M, respectively (Table 2). The rtMC2R show a similar
response to these analogs (Lisa Liang, Ph.D. Thesis, 2013). For xtMC2R and rtMC2R it
appears that the interaction with positions 15 and 16 in the KKRRP motif might be more
important for activation than interaction at positions 17, 18, and 19. Just the opposite was
observed for hMC2R (Liang et al., 2013).
Figure 31: Amino Acid Sequences of ACTH in Multiple Species
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Analysis of Zone B Analogs of hACTH(1-24)
It is surprising that since the studies by Schwyzer and colleagues on ACTH truncated
analogs (Schwyzer, 1977), no analog studies have been done on the GKRVG (Zone B)
motif of ACTH until recent thesis projects in our lab. The rationale for these experiments
was that the GKRVG motif has been conserved in vertebrate evolution because this motif
serves as “linker” region between the HFRW motif and KKRRP motif to properly
position these motifs on the surface of MC2R so that the activation event can proceed
(Liang et al., 2013). The results of the alanine substitution experiments on xtMC2R,
hMC2R, and rtMC2R support this assumption. As shown for xtMC2R in Table 2, either
single alanine substitution or double alanine substitution in this region of the ligand
affected the EC50 value in a negative manner. However, the most compelling argument
for the importance of the GKPVG motif came from the truncation experiments. When the
hACTH(1-24) sequence was shortened to the ACTH(1-21) or the ACTH(1-22) analog
(Table 1) there was a complete lack of stimulation of, not only xtMC2R (Table 2), but
also hMC2R and rtMC2R (Lisa Liang, Ph.D. thesis). Collectively, the results from the
alanine substitution and the shortened Zone B ligand experiments underscore the
importance of the secondary structure of Zone B (GKPVG), and suggest that this motif
may play a crucial role in positioning the HFRW and KKRRP motifs, so that proper
interaction of the ligand and receptor could occur to result in activation of the MC2Rs.
These observations have led to the following hypothesis to account for the activation of
tetrapod and teleost MC2Rs (Figure 32). This mechanism requires that tetrapod and
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teleost MC2Rs interact with the MRAP1 homodimer at the rough endoplasmic reticulum.
In the absence of MRAP1 the receptor will miss-fold and be degraded by the protein
quality control mechanism in the endoplasmic reticulum (Hinkle and Sebag, 2010).
Figure 32A: Proposed Model of MC2R Activation
In the Presence of MRAP1 At the Plasma Membrane
SYSMEHFRWGKPV

HFRW
KKRRP

Pre-activation State

As shown in Figure 32A, MC2R is positioned on the plasma membrane, in
contact with MRAP1, and in a “pre-activation” state. Based on the ligand and analog
studies we assume that there are two binding sites on the receptor. The KKRRP binding
site is exposed, but the HFRW binding site is not accessible in the pre-activation state. As
a result in the pre-activation state, α-MSH cannot activate the receptor. However, as
shown in Figure 32B, when ACTH(1-24) makes contact with the receptor, the KKRRP
motif on ACTH(1-24) can interact with the exposed KKRRP binding site on the receptor.
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This event would be Step 1 of the activation process. The argument to support the Step 1
event comes from the observations by Lisa Liang (Ph.D thesis) that the analog ACTH(1524) blocks the binding of ACTH(1-24) to the receptor and inhibits activation as a result.
Figure 32B: Proposed Model of MC2R Activation
In the Presence of MRAP1 At the Plasma Membrane
SYSMEHFRWGKPVGKKRRPVKVYP
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KKRRP
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Activation Step 1 – bind to KKRRP binding site

For this proposed mechanism, the prediction is that the docking at the KKRRP
binding site results in a conformation change in the receptor (Figure 32C). This
conformation change exposes the HFRW binding site. This is Step 2 of the activation
process. Because of the “linker” role that the GKPVG motif plays, the HFRW motif in
the ligand is properly positioned to interact with the exposed HFRW binding site on the
receptor. The later interaction is predicted to induce another conformational change in the
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receptor (Step 3) which results in the activation of the G protein and induces the
subsequent biological response within the target cell.
Figure 32C: Proposed Model of MC2R Activation
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Based on this model, and given the slightly different responses to the Zone A, B,
and C analogs observed for xtMC2R, hMC2R, and rtMC2R it would appear that
difference in primary sequence (Figure 30) could contribute to subtle changes in the 3dimensional shape of these receptors. Confirmation of this conclusion will depend on
molecular 3-dimensional modeling of the tetrapod and teleost MC2Rs.
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Tetrapod and Teleost MC2Rs: Mutant Receptor Studies – the KKRRP site on MC2R
As introduced in the preceding section, there is an extensive literature on the
binding and signaling by α-MSH for mammalian MC1R, MC3R, and MC4R (Yang et al.,
2000; Chen et al., 2006). Furthermore, the study by Pogozheva et al. (2005) identified the
HFRW binding site which is common to all melanocortin receptors including the MC2
receptor. Table 4 (Liang, 2013) summarized the comparison between hMC4R, hMC2R,
xtMC2R and rtMC2R in support of the assumption that all melanocortin receptors have a
common HFRW binding site.
Table 4: Proposed HFRW binding sites in MC4R and the corresponding residues of
MC2R

Although a high level of sequence similarity was found for the proposed HFRW
binding sites on melanocortin receptors, there is still the question of where the docking
site for the R/KKRRP is located within the melanocortin 2 receptor sequence. Working
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from the model presented in Figure 33, this thesis focused on the TM 4, extracellular loop
2 (EL2), and the TM5 regions of xtMC2R.
Figure 33: 3-Dimensional Diagram of the MC2R binding sites for the HFRW and
R/KKRRP motifs

The single alanine substitution experiments for xtMC2R are summarized in
Figure 34A. There were nine residues in TM4, EL2, and TM5 that appear to be
important, from a statistical perspective, for the activation of xtMC2R by hACTH(1-24)
(see Table 3). However, as noted in the Results section, the alanine mutants that resulted
in at least a 10 fold shift in EC50 values, relative to the positive control, were: A173, I175,
F178, D180, A182, M183, and I184. Since the A173 and A182 sites are considered intrinsically
inert in the wild-type receptor, we feel that the substitution of a glutamine residue at these
two positions most likely disrupted natural interactions between the ligand and the
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receptor. Hence, the critical sites for facilitating activation of xtMC2R are: I175, F178,
D180, , M183, and I184. Among these positions a 50 fold or greater shift in EC50 values was
observed for I175, F178, and I183, and a 100 fold or greater shift in EC50 values was
observed for the I/A175 mutant and the I/A183 mutant. It would appear then that positions
I175, F178, and I183 are the most important for activation of xtMC2R following the ligand
binding event (Step1; Figure 33).
Recently, single alanine substitutions were performed on the TM4, EL2, and TM5
regions of hMC2R and rtMC2R (Lisa Liang, Ph.D. thesis, 2013). For hMC2R and
rtMC2R a set of amino acid positions were also identified in these regions that affected
EC50 values by at least 10 fold (Figure 34C). While the model presented in Figure 33
targets TM4, EL2, and TM5 as the most likely location for the KKRRP docking site, a
comparison of the primary sequences of xtMC2R, hMC2R, and rtMC2R resulted in a
number of surprising observations (Figure 34B).
The underlined residues in Figure 34B were the amino acids positions that were
targeted for single alanine or glutamine replacement. For TM4 and TM5 site directed
mutagenesis was performed on the seven amino acid positions closest to the extracellular
space. The rationale for selecting these positions was that Pogosheva et al. (2005)
observed that the amino acid positions involved for the HFRW binding site are located
within seven residues of the surface of the cell. Hence, it seemed reasonable to predict
that the hydrophilic pocket for the KKRRP docking site would also be relatively close to
the surface of the cell. The feature that is striking about Figure 34B is that the alignment
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of the sequences of xtMC2R, hMC2R, and rtMC2R indicated that within the underlined
zone only three positions are identical in the three receptors (residues in red). An
additional eight positions (pink) have amino acids in the same group (i.e., hydrophobic,
polar uncharged, or polar same charge). Hence, the striking feature is the lack of primary
sequence identity in this region of the three receptors.
In terms of functionality, the critical positions in xtMC2R that have at least a 10 fold
influence on EC50 value are located within TM4 and EL2 (Figure 34C), and the positions
in this receptor that have a 100 fold or greater effect on EC50 value were located in TM4
and EL2. Note that positions in TM5 do not appear to be essential for the activation of
xtMC2R. When the same comparison is done for hMC2R, the positions with at least a 10
fold influence on EC50 value are located in EL2 and TM5, the position in hMC2R that
had a 100 fold or greater effect on EC50 value was restricted to a single position in TM5.
Note the apparent absence of a role for TM4 in the activation of hMC2R. These
observations are in contrast to rtMCR2 where the positions that had at least a 10 fold or
100 fold influence on EC50 value are located within TM4 and TM5. Note that for
rtMC2R, the EL2 region does not appear to be important for the activation of the
receptor. Collectively these observations indicate that while the TM4/EL2/TM5 region of
these MC2Rs appears to be the target for the docking of the KKRRP motif of ACTH; the
primary sequence of this zone in the three receptors do not provide a simple explanation
for where the KKRRP docking event (Step 1) will occur. The prediction would be that
the 3-dimensional shape of the TM4/EL2/TM5 region must be similar in all three
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receptors. Another prediction is that the interaction between the KKRRP motif of ACTH
and the corresponding docking site on the receptor relies upon hydrogen bonding and
hydrophobic interactions between the R-groups rather than ionic interactions (note the
absence of acidic amino acids in this region with the exception of the lone aspartic acid
reside (D) in EL2 of xtMC2R. At this stage, it would difficult to obtain further
information from additional site-directed mutagenesis experiments. The next step should
be to do molecular 3-dimensional modeling of these receptors.
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Figure 34: Tetrapod/Teleost Comparison of MC2R Single Alanine Substitutions
A. xMC2R: Summary of single alanine substitution
[--------TM4---------]

EL2

[-------TM5---------]

xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF

B. Sequence identity in TM4,EL2,and TM5 of hMC2R,xMC2R and
rtMC2R
[--------TM4---------]

ELC2

[-------TM5---------]

xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF
hMC2R RTVVVLTVIWTFCTGTGITMVIFSHHVPTVITFTSLFPLMLVFILCLYVHMF
rMC2R RAAAALAGIWALCGVAGAVMVAFCDATVIKIFFIVLFLISLLLILFLYVHMF

C. Mutations that resulted in a 10 fold or greater shift in
EC50

[--------TM4---------]

EL2

[-------TM5---------]

xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF
hMC2R RTVVVLTVIWTFCTGTGITMVIFSHHVPTVITFTSLFPLMLVFILCLYVHMF
rMC2R RAAAALAGIWALCGVAGAVMVAFCDATVIKIFFIVLFLISLLLILFLYVHMF
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D. Mutations that resulted in a 100 fold or greater shift
in EC50

[--------TM4---------]

EC2

[-------TM5---------]

xMC2R RASVILAVIWTFCGGSGIAIIMLFHDTAMIICLTVMFLLLLVLIVCLYIHMF
hMC2R RTVVVLTVIWTFCTGTGITMVIFSHHVPTVITFTSLFPLMLVFILCLYVHMF
rMC2R RAAAALAGIWALCGVAGAVMVAFCDATVIKIFFIVLFLISLLLILFLYVHMF

Final Observations
Based on the observations made in this thesis, xtMC2R has several basic properties
that are identical to mammalian MC2Rs. It appears that all of the tetrapod MC2Rs can
only be activated by ACTH, but not by any MSH-sized melanocortin ligand. In addition,
all of the tetrapod MC2Rs require interaction with MRAP1 to facilitate functional
activation of the receptor at the plasma membrane following stimulation with ACTH
(Gantz and Fong, 2003; Hinkle and Sebag, 2009; Webb and Clark, 2010). This thesis has
examined the effects of alanine substitutions in the functional zones of hACTH(1-24)
(Table1). The operating assumption was that there would be a differential response of
amniote MC2Rs (e.g. human) to these analogs of hACTH(1-24) as compared to the
response of an anamniote MC2R (i.e., frog) to the same analogs. However, the outcome
of this analysis did not neatly follow this simple dichotomy of the tetrapod MC2R
sequences.
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The analysis of alanine-substituted analogs of the H6F7R8W9 motif of hACTH(1-24)
indicated that xtMC2R could not tolerate any single alanine substitution in this motif
(Davis et al., 2013). By contrast, human MC2R could tolerate some alanine substitutions
in the H6F7R8W9 motif (Liang et al., 2013). These observations may indicate subtle
differences in the 3-dimensional structure of the HFRW binding sites of tetrapod MC2Rs.
Similar results were observed when the alanine substituted analogs of the
K15K16R17R18P19 motif of hACTH(1-24) were analyzed. For xtMC2R it appears that
positions 15 and 16 in the ligand are far more important for activation of the receptor
(Table 2) than positions 17, 18, and 19 (Davis et al., 2013); whereas, for human MC2R,
positions 17, 18, and 19 are clearly more essential for activation of the receptor (Liang et
al., 2013). Figure 34 shows the proposed location of the putative KKRRP binding in
MC2Rs. Given the lack of primary sequence identity in this region, secondary and
tertiary structures at this proposed docking site would appear to be the critical factors for
mediating the activation of these receptors.
The analysis of the G10K11R12V13G14 motif in hACTH(1-24) provided further
evidence for the importance of this region of the ligand for activation of the receptor.
These observations also may explain the nearly universal conservation of this motif in
gnathostome ACTH sequences (Dores and Lecaude, 2005). With respect to the alanine
analogs of the GKPVG motif, the response of hMC2R (Liang et al, 2013) was distinct
from the response of xtMC2R (Table 2). In addition, the analysis of the ACTH(1-21) and
the ACTH(1-22) analogs do point to the importance of the spatial positioning of the
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HFRW binding site and the putative KKRRP binding site in tetrapod MC2Rs with
respect to the proposed 3 step mechanism for the activation of the receptor (Figure 32).
When these observations are viewed collectively, the response of xtMC2R to these
ACTH(1-24) analogs was subtly different than the response of hMC2R to these same
analogs. It is possible that mammalian MC2Rs have evolved structural features distinct
from the non-mammalian MC2Rs. At present, the data set is small and the
generalizations should be viewed conservatively until modeling of the 3-dimensional
shape of these receptors has been done.
That said, the additional structure/function data provided in this thesis add to the
growing literature on the distinctive features of melanocortin-2 receptor orthologs in
teleosts and tetrapods (Agullerio et al., 201; Liang et al., 2011). In this regard, the
exclusive selectivity for ACTH and the requirement for interaction with an MRAP1
ortholog are the two features which unite teleost and tetrapod MC2 receptor orthologs.
The dependence of both teleost and tetrapod MC2Rs on MRAP1 for functional activation
raises the question of whether there is an ortholog of MC2R that is MRAP independent.
As noted in the Introduction, an MC2R ortholog detected in the genome of the
cartilaginous fish, Callorhinchus milii [48], indicates that the C. milii MC2 receptor
ortholog is MRAP independent. These observations would suggest that in the early
evolution of the gnathostomes a MC2R-like receptor and a MRAP-like accessory protein
functioned independent of each other. In this scenario following the divergence of the
ancestral cartilaginous fish and the ancestral bony fish lineages, an interaction developed
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between MC2R and MRAP1 that initially may have been neutral from a fitness
perspective. However, as point mutations accumulated in the ancestral bony fish MC2R
ortholog, the interaction with MRAP1 became essential for the functional activation of
the receptor. The rescue of a misfolded MC2R by MRAP1 may have been a critical event
during the early evolution of the bony fishes. Hence, the co-evolution of the MC2R gene
and the MRAP1 gene appears to have been an important event in the evolution of the
bony vertebrates (i.e., bony fishes, amphibians, reptiles, birds, and mammals.
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